The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
BIOGEN INC COM 09062X103 5,897 28,000 SH   SOLE   28,000 0 0
BRISTOL-MYERS SQUIBB CO COM 110122108 5,988 82,000 SH   SOLE   82,000 0 0
CARDINAL HEALTH INC COM 14149Y108 5,670 100,000 SH   SOLE   100,000 0 0
CIGNA CORP NEW COM 125523100 5,751 24,000 SH   SOLE   24,000 0 0
GILEAD SCIENCES INC COM 375558103 5,826 98,000 SH   SOLE   98,000 0 0
HARMONY BIOSCIENCES HLDGS IN COM 413197104 5,838 120,000 SH   SOLE   120,000 0 0
IRONWOOD PHARMACEUTICALS INC COM CL A 46333X108 8,932 710,000 SH   SOLE   710,000 0 0
KEMPHARM INC COM NEW 488445206 1,283 255,000 SH   SOLE   255,000 0 0
LA JOLLA PHARMACEUTICAL CO COM 503459604 3,019 707,000 SH   SOLE   707,000 0 0
MCKESSON CORP COM 58155Q103 9,184 30,000 SH   SOLE   30,000 0 0
OPIANT PHARMACEUTICALS INC COM 683750103 386 18,000 SH   SOLE   18,000 0 0
UTAH MED PRODS INC COM 917488108 5,032 56,000 SH   SOLE   56,000 0 0